Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$6,585,615
-$12,887,583 QoQ
Shares Held
273,489
-60.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#524
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GREAT LAKES ADVISORS, LLC holds $574,710,667 across 11 Drug Manufacturers - General names. PFE ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
1,595,891 | $205,071,992 | |
| 2 | ABBV |
AbbVie Inc.
|
564,465 | $142,041,969 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
1,069,621 | $135,135,914 | |
| 4 | AMGN |
Amgen Inc
|
107,992 | $39,106,062 | |
| 5 | LLY |
ELI LILLY & Co
|
18,830 | $22,585,267 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
192,181 | $11,073,468 | |
| 7 | PFE |
Pfizer Inc
This page
|
273,489 | $6,585,615 | |
| 8 | NVS |
Novartis AG
|
34,195 | $5,359,039 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,585,615 | 273,489 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $19,473,198 | 693,490 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $12,955,046 | 520,283 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,089,473 | 42,758 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $700,366 | 28,893 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,036,905 | 80,383 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $443,395 | 16,713 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $509,315 | 17,599 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $506,242 | 18,093 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $372,821 | 13,435 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $393,472 | 13,667 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $673,715 | 20,311 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $513,630 | 14,003 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,987,327 | 48,709 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,430,671 | 47,437 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $902,681 | 20,628 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,005,869 | 19,185 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,117,817 | 21,592 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,416,963 | 23,996 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,042,992 | 24,250 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $872,798 | 22,288 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $818,942 | 22,604 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $871,145 | 23,666 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $865,898 | 23,594 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $754,749 | 23,081 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $797,100 | 24,421 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||